In this issue:
- CV risk and health in people with HIV eligible for primary prevention
- Collaboration to increase syphilis and HIV screening in the ED
- Tobacco use and treating dependence in people with HIV
- Integrating HIV and other health services
- Advanced HIV infection in treatment-naïve individuals: recommended 3-drug regimens
- Meth facilitates HIV infection of primary human monocytes
- Switching to dolutegravir/lamivudine vs. continuing TAF regimen in HIV-1
- Epidemiological impact of the UNAIDS 2025 targets to end AIDS by 2030
- Uptake success and cost savings from switching to two-drug ART
- Overcoming barriers to PrEP for Medicare-ineligible Australians at risk of HIV
Please login below to download this issue (PDF)